Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jos N Hoes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|January 28, 2015
Management of osteoporosis in rheumatoid arthritis patientsJos N Hoes, Irene E M Bultink, Willem F Lems
Rheumatology (Oxford, England)|April 15, 2011
Glucocorticoids are forever?Jos N Hoes, Johannes W G Jacobs, Johannes W J Bijlsma
Nederlands Tijdschrift Voor Geneeskunde|January 8, 2015
[A woman with ischemia of the eyes and the left arm]Remy H H Bemelmans, Jos N Hoes, Marnix G E H Lam
Nature Reviews. Rheumatology|December 2, 2010
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritisJos N Hoes, Johannes W G Jacobs, Frank Buttgereit, et al.
Calcified Tissue International|January 10, 2018
Glucocorticoids, Inflammation and BoneMelek Güler-Yüksel, Jos N Hoes, Irene E M Bultink, et al.
Annals of the New York Academy of Sciences|July 21, 2006
Are glucocorticoids DMARDs?Johannes W J Bijlsma, Jos N Hoes, Amalia A Van Everdingen, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapyJohannes W J Bijlsma, Marlies C van der Goes, Jos N Hoes, et al.
Rheumatology (Oxford, England)|August 20, 2011
Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritisJos N Hoes, Marlies C Van der Goes, Johannes W G Jacobs, et al.
Arthritis and Rheumatism|September 29, 2011
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reductionDebby den Uyl, Daniel H van Raalte, Michael T Nurmohamed, et al.
Clinical and Experimental Rheumatology|April 22, 2010
High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trialJos N Hoes, Johannes W G Jacobs, Harry M J Hulsmans, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|January 28, 2015
Management of osteoporosis in rheumatoid arthritis patientsJos N Hoes, Irene E M Bultink, Willem F Lems
Rheumatology (Oxford, England)|April 15, 2011
Glucocorticoids are forever?Jos N Hoes, Johannes W G Jacobs, Johannes W J Bijlsma
Nederlands Tijdschrift Voor Geneeskunde|January 8, 2015
[A woman with ischemia of the eyes and the left arm]Remy H H Bemelmans, Jos N Hoes, Marnix G E H Lam
Nature Reviews. Rheumatology|December 2, 2010
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritisJos N Hoes, Johannes W G Jacobs, Frank Buttgereit, et al.
Calcified Tissue International|January 10, 2018
Glucocorticoids, Inflammation and BoneMelek Güler-Yüksel, Jos N Hoes, Irene E M Bultink, et al.
Annals of the New York Academy of Sciences|July 21, 2006
Are glucocorticoids DMARDs?Johannes W J Bijlsma, Jos N Hoes, Amalia A Van Everdingen, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapyJohannes W J Bijlsma, Marlies C van der Goes, Jos N Hoes, et al.
Rheumatology (Oxford, England)|August 20, 2011
Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritisJos N Hoes, Marlies C Van der Goes, Johannes W G Jacobs, et al.
Arthritis and Rheumatism|September 29, 2011
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reductionDebby den Uyl, Daniel H van Raalte, Michael T Nurmohamed, et al.
Clinical and Experimental Rheumatology|April 22, 2010
High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trialJos N Hoes, Johannes W G Jacobs, Harry M J Hulsmans, et al.
Pageof 1